March 5, 2007
HOFFMAN ESTATES, Ill., and COLLEGEVILLE, Pa., March 5, 2007 ― The Molecular Imaging division of Siemens Medical Solutions (www.usa.siemens.com/medical), a leading provider of molecular imaging equipment, molecular imaging tracers and services, today announced an agreement with Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), to utilize Siemens’ new research imaging agent in Wyeth’s clinical studies of new therapies in development for Alzheimer’s disease. More